Immunosuppression with calcineurin inhibitors and polyclonal antibodies in liver transplantation.
Rafecas
A
A
Liver Transplant Unit, C.S.U. Bellvitge, L'Hospitalet De Llobregat, Barcelona, Spain.
Lladó
L
L
Albiol
M T
MT
Ramos
E
E
Torras
J
J
Fabregat
J
J
Lama
C
C
Busquets
J
J
Ibáñez
L
L
Figueras
J
J
Jaurrieta
E
E
D000906:Antibodies / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007239:Infections / Q000145:classification / Q000453:epidemiology; D016031:Liver Transplantation / Q000276:immunology*; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors
D000906:Antibodies; D000961:Antilymphocyte Serum; D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone; D016559:Tacrolimus